Clarivate Plc
NYSE:CLVTInformation Technology Services
-$0.10 today
- Market cap
- $1.38B
- Beta
- 1.37
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$0.21
Volume 3.95M
Average 5.22M
CLVT Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Clarivate PlcNYSE: CLVT
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures dips below year-ago levels
Q1 FY2026 capital expenditures of $55.8M (cash outflow) fell 8.4% year over year, behind the +101.8% change in trailing-twelve-month capital expenditures. Over 3 fiscal years it compounded at +9.1% a year.
Context
- Capital expenditures amounted to 10.7% of revenue in FY2025, down 0.6 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -8.4% toward the trailing-twelve-month pace of +101.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (263.2M) USD
- Year-over-year change
- +9.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (263.2M) | +9.0% |
| FY2024 | 2024-12-31 | (289.1M) | -19.2% |
| FY2023 | 2023-12-31 | (242.5M) | -19.5% |
| FY2022 | 2022-12-31 | (202.9M) | -71.2% |
| FY2021 | 2021-12-31 | (118.5M) | — |
Capital Expenditures vs competitors
How CLVT compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +101.8% is the highest of 9, against a peer median of -17.7%.
- Capital expenditures amounts to 0.2% of revenue for CLVT, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥7.84B CNY | +63.9% | +37.1% | 75.8% | |
| LTM Sep 2026 | $258M USD | +4.9% | -7.4% | 2.1% | |
| LTM Feb 2026 | $237.78M USD | +1.9% | +18.8% | 2.4% | |
| LTM Dec 2025 | $16.31M USD | — | -25.4% | 0.6% | |
| LTM Mar 2026 | $16.19M USD | -51.8% | -41.4% | 0.7% | |
| LTM Jun 2026 | $14.78M USD | +91.1% | +19.4% | 4.7% | |
| LTM Mar 2026 | $13.3M USD | -39.2% | -14.7% | 1.0% | |
| LTM Mar 2026 | $5.1M USD | +101.8% | +9.1% | 0.2% | |
| LTM Mar 2026 | $3.07M USD | -60.8% | -11.9% | 2.4% | |
| LTM Apr 2026 | $1.91M USD | -37.2% | -70.1% | 0.8% | |
| Peer median (excluding CLVT) | — | -17.7% | -11.9% | 2.1% | |
Competitors are the stored peer set for CLVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (270.5M) | (3.96B) | (911.2M) | (636.7M) | (201.1M) |
| Depreciation & Amortization | 537.8M | 710.5M | 708.3M | 727M | 757.2M |
| Deferred Income Tax | (13.3M) | (54.3M) | (78.4M) | 21.2M | (41.5M) |
| Stock-Based Compensation | 33.3M | 93.9M | 109M | 59.9M | 63.1M |
| Change in Working Capital | 68M | (271.9M) | (60.4M) | (24.9M) | 3.5M |
| Accounts Receivables | (64.1M) | (28.3M) | (25.5M) | 92.6M | (5M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 31.2M | (24M) | 41.2M | (15M) | 22.8M |
| Other Working Capital | 100.9M | (219.6M) | (76.1M) | (102.5M) | (14.3M) |
| Other Non-Cash Items | (31.5M) | 3.99B | 976.9M | 500.1M | 47.3M |
| Operating Cash Flow | 323.8M | 509.3M | 744.2M | 646.6M | 628.5M |
| Capital Expenditures | (118.5M) | (202.9M) | (242.5M) | (289.1M) | (263.2M) |
| Acquisitions (Net) | (3.93B) | 260.2M | 5.1M | (32M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 84.4M | 0 |
| Investing Cash Flow | (4.04B) | 57.3M | (237.4M) | (236.7M) | (263.2M) |
| Debt Repayment | 1.99B | (496.5M) | (301M) | (198.1M) | (109.4M) |
| Common Stock Issued | 867.9M | 5.7M | 0 | 0 | 0 |
| Common Stock Repurchased | (159.4M) | (175M) | (100M) | (200M) | (224.5M) |
| Dividends Paid | (18.9M) | (75.4M) | (75.5M) | (37.7M) | 0 |
| Other Financing Activities | (38.8M) | (12.3M) | (20.5M) | (34.3M) | (9.2M) |
| Financing Cash Flow | 4.03B | (759.2M) | (496.5M) | (470.1M) | (343.1M) |
| Effect of Forex Changes | 3.7M | (38.2M) | 3.6M | (15.3M) | 11.8M |
| Net Change in Cash | 315.2M | (230.8M) | 13.9M | (75.5M) | 34M |
| Free Cash Flow | 205.3M | 306.4M | 501.7M | 357.5M | 365.3M |
Clarivate Plc
NYSE:CLVT
Intrinsic Alpha fair value
Locked
Current Price
$2.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.